Flu Vaccines and Vaccination: Opportunities and Challenges for All Age Groups

These days success and challenges of vaccines on infants, children, pregnant women and elderly patient is major concern for influenza research. Evidence-based guidelines for immunization of infants, children, adolescents, and adults have been prepared by an Expert Panel of the Infectious Diseases Society of America (IDSA). These guidelines are prepared for health care professionals who care for either immunocompetent or immunocompromised people of all ages. Vaccine innovation and human health researchers try to determine how well flu vaccines work to regularly assess and confirm the value of flu vaccination as a public health intervention in each season. Study results about how well a flu vaccine works can vary based on study design, outcome(s) measured, population studied and the season in which the flu vaccine was studied. These differences can make it difficult to compare one study’s results with another’s. rough the support of the U.S. Department of Health and Human Services and NIAID, researchers are developing various influenza vaccine delivery technologies that will help the United States and the world be better prepared to mount a speedy response to the next pandemic

Influenza is a serious disease that can lead to hospitalization and sometimes even death. Two types of influenza vaccines include the injection containing killed virus and nasal spray vaccines which containing live but weakened virus. The effectiveness of the flu vaccine is dependent upon the extent of the match between the virus strains used to prepare the vaccine and those viruses in actual circulation. Two factors age and health status of the individual play important role in determining the effectiveness of the vaccine. The vaccine is usually recommended for everyone 6 months of age or older. Anyone at risk for developing serious complications from the flu should also receive the flu vaccine, including pregnant women, people over 65, and individuals with chronic diseases and their caregivers. The vaccine is not recommended for people who have allergies to chicken eggs or people who have had an allergic reaction to the shot in the past.

  • Vaccine innovation and human health
  • Effectiveness of multivalent vaccines
  • Developing a universal flu vaccine
  • Success and challenges of vaccines on infants, children, pregnant women and elderly patient
  • Various influenza vaccine delivery technologies

Related Conference of Flu Vaccines and Vaccination: Opportunities and Challenges for All Age Groups

Flu Vaccines and Vaccination: Opportunities and Challenges for All Age Groups Conference Speakers